Ed Hodgkin

In this engaging discussion, Ed Hodgkin, managing partner at Syncona, sheds light on the urgent challenges academia faces amid shifting VC priorities and federal funding risks. He emphasizes the need for innovative collaboration between academia and pharma to unlock first-in-class innovations. The exploration of drug development complexities and advancements in delivery systems reveals a bright future for biopharmaceuticals, while also addressing endometriosis challenges and the exciting potential of Europe’s biotech landscape.